Pharma Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Collaborations
Abbott Laboratories grants rights for new cancer and transplantation drug tests
February 27th, 2006
Bayer HealthCare, Diagnostics Division, a member of the Bayer Group (BAY), announced that it has been granted licenses under key patent rights relating to free PSA and tacrolimus tests from Abbott Laboratories. Bayer intends to develop these two new tests for its Advia Centaur and Advia Centaur CP immunoassay systems immediately. "By adding free PSA to the oncology portfolio, Bayer HealthCare Diagnostics will have a very comprehensive diagnostic menu for prostate cancer markers," said Samir Taneja, MD, director of Urologic Oncology, NYU Cancer Institute and School of Medicine. The flexibility will allow physicians to select the tests they feel most appropriate to...
Source: Pharma Business Week (2006-02-27)
|
